Sophrosyne Capital’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History

Sophrosyne Capital’s Portfolio ZLTQ Stock Details ZLTQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-146,097	Closed	-$4.51M	–	27
2015 Q1	$4.51M	Sell	146,097 -46,500	-24%	-$1.49M	7.73%	3
2014 Q4	$5.38M	Sell	192,597 -191,821	-50%	-$5M	8.29%	2
2014 Q3	$8.7M	Sell	384,418 -44,286	-10%	-$877K	10.26%	1
2014 Q2	$6.51M	Buy	428,704 +40,700	+10%	+$696K	6.63%	4
2014 Q1	$7.61M	Sell	388,004 -120,900	-24%	-$2.36M	6.66%	2
2013 Q4	$9.62M	Sell	508,904 -110,700	-18%	-$1.58M	8.43%	2
2013 Q3	$5.59M	Buy	619,604 +36,386	+6%	+$270K	3.7%	7
2013 Q2	$3.73M	Buy	+583,218	New	+$2.77M	2.92%	14

Other funds holding ZLTQ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sophrosyne Capital's ZLTQ Position: Q2 2015 in Review

Sophrosyne Capital sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2015, closing a stake of 146,097 shares — an estimated $4.51M sold.

Sophrosyne Capital first reported a position in ZLTQ in Q2 2013 and held it in 8 quarters. The position peaked at $9.62M in Q4 2013. 152 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2015.

Sophrosyne Capital reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2015 after selling out during the quarter.
Sophrosyne Capital sold 146,097 ZELTIQ Aesthetics, Inc. shares in Q2 2015, an estimated $4.51M.
Sophrosyne Capital first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 8 quarters.
Sophrosyne Capital's ZELTIQ Aesthetics, Inc. position peaked at $9.62M in Q4 2013.
152 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2015.

Based on Sophrosyne Capital's 13F filing for Q2 2015, filed 14 Aug 2015.